Richard S. Lindahl - 23 Feb 2022 Form 4 Insider Report for Emergent BioSolutions Inc. (EBS)

Role
EVP, Chief Financial Officer
Signature
/s/ S. Scott Lieberman, Attorney-in-fact
Issuer symbol
EBS
Transactions as of
23 Feb 2022
Net transactions value
-$63,539
Form type
4
Filing time
25 Feb 2022, 16:18:22 UTC
Previous filing
24 Feb 2022
Next filing
02 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EBS Common Stock Tax liability $21,791 -516 -1.3% $42.23* 38,941 23 Feb 2022 Direct F1
transaction EBS Common Stock Tax liability $41,748 -983 -2.5% $42.47* 37,958 24 Feb 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock withheld by the Company in exchange for payment of the employee's withholding taxes.